Tentt

Ouro Medicines Acquired by Gilead Sciences — Healthcare M&A

Announced
HealthcareMerger

Deal Summary

Gilead Sciences announced plans to acquire Ouro Medicines for about $2B.

Key Details

Transaction
Gilead Sciences acquires Ouro Medicines
Deal Size
Over $100M
Reported Value
$2B

Source

Read full article on news.google.com

via Google News - themiddlemarket.com · March 23, 2026

Related Deals